$MOH

Here's What Key Metrics Tell Us About Molina (MOH) Q2 Earnings

Molina (MOH) reported Q2 results versus analyst estimates. Medical loss ratios were 92.7% (Medicaid), 90.7% (Medicare), and 88.9% (Marketplace). Total ending membership was 4.93M. Premium revenue totaled $10.24B, below the $10.43B estimate, while premium tax revenue was $505M above estimates.

Original reporting
Published Jul 22, 2026, 10:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 23, 2026, 1:53 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Here's What Key Metrics Tell Us About Molina (MOH) Q2 Earnings — source image
Decision brief

The 30-second read

$MOHNeutralMed
01

Why it matters

Traders can use the beat-miss pattern to reassess near-term earnings power, especially the Marketplace premium revenue weakness versus premium tax revenue strength.

02

Market read

Mixed Q2 results across utilization (MCR) and revenue components suggest a nuanced market reaction rather than a single-direction thesis.

03

What to watch

The excerpt lacks management commentary, guidance, and segment margin details, which are often the key drivers of follow-through after earnings.

Relevance 6/10Novelty 6/10Timing: after-hours earnings metrics for Q2 (published 2026-07-22)

Background

The article summarizes Molina’s Q2 performance using MCR rates, membership counts, and premium revenue components versus consensus estimates.

Company-level read

Ticker impact

$MOHNeutralMedium confidence
Context

Molina (MOH) reported Q2 Medicaid, Medicare, and Marketplace MCR rates plus membership and premium revenue figures versus analyst estimates.

Expected impact

Likely modest post-earnings volatility, with traders focusing on the Marketplace premium revenue miss versus the premium tax revenue beat.

Evidence & confidence

The article provides multiple quantified beats and misses (MCR, membership, and premium revenue lines) but no guidance, outlook, or new corporate event beyond the earnings datapoints.

Market effects

Managed care insurers may see read-across on Medicaid/Marketplace cost trends and premium mix, but this is company-specific earnings detail.

No explicit regional policy or contract changes are disclosed in the text.

Limited, as the disclosure is US managed-care earnings metrics.

Counterpoint

The Marketplace premium revenue miss could be offset by favorable premium tax revenue and stable Medicaid/Medicare MCR, reducing downside risk.

Key entities

  • Molina Healthcare

    Subject of the article, with Q2 MCR, membership, and premium revenue metrics reported versus analyst estimates.

Related articles

$MOHMedAI 8/10

Molina Healthcare Q2 Earnings Call Highlights

Molina Healthcare (MOH) discussed Q2 results on its earnings call. Medicaid MCR was 92.4% in first half, expected to rise to 93.3% in second half. Medicare MCR was 90.7% and full-year Medicare MCR guidance was cut to 92.2%, with 2026 EPS contribution of $0.25. Marketplace MCR pressure led to raised 2026 guidance to 90% and a shift to a $0.75 per share loss. 2027 premium outlook is about $46.5B.

$MOHMedAI 8/10

Molina Healthcare Posts Lower Q2 Earnings, Raises Full-Year Guidance; Stock Down

Molina Healthcare (MOH) reported Q2 2026 revenue of $10.87B, down 5% from Q2 2025, with GAAP net income falling to $60M ($1.19/share) from $255M ($4.75). Adjusted net income was $77M ($1.51). Medical care ratio rose to 92.2%. Despite weaker results, the company raised full-year guidance for GAAP earnings to at least $2.15/share and adjusted to at least $5.25/share.

$MOHMedAI 8/10

Why is Molina Healthcare stock sliding today? By Investing.com

Molina Healthcare (MOH) fell about 9.2% in pre-open trading after reporting Q2 2026 results. Adjusted EPS was $1.51 vs. ~$1.39–$1.40 expected, and revenue was ~$10.87B. Full-year 2026 revenue guidance was ~$42B vs. ~$44.28B consensus, with Medicaid margin “trough year” comments, enrollment pressure, and Florida CMS contract startup costs cited.

$MOHMedAI 8/10

Molina raises full year 2026 guidance after Q2 results

Molina Healthcare reported Q2 2026 adjusted EPS of $1.51, above the $1.39 consensus. Revenue fell to $10.874B from $11.427B a year earlier, while GAAP net income declined to $60M. The company raised full-year 2026 adjusted guidance to at least $5.25 per diluted share and GAAP to at least $2.15. Analysts at RBC, Wells Fargo, and TD Cowen raised price targets for MOH.

$MOHMedAI 8/10

Molina Healthcare stock falls as first-half EPS covers 73.5% of 2026 floor

Molina Healthcare (NYSE:MOH) shares fell 9.4% to $200.85 after hours after its first-half adjusted EPS covered 73.5% of its new 2026 EPS floor. Adjusted EPS was $3.86 in the first half versus a $5.25 floor, leaving a $1.39 gap. Premium revenue fell 6% and medical costs rose, with guidance changes tied to Medicaid, Medicare, and Marketplace.

$MOHMed

Molina (MOH) Q2 Earnings Top Estimates

Molina (MOH) reported Q2 adjusted EPS of $1.51, above the Zacks Consensus of $1.37, an earnings surprise of +10.22%. Revenue was $10.87B, slightly below consensus by 0.08%, versus $11.43B a year earlier. For the next quarter, consensus calls for EPS of $1.01 on $11.06B revenue, and FY EPS of $5.23 on $44.41B revenue.